TEE
VYGR icon

Tibra Equities Europe’s Voyager Therapeutics VYGR Stock Holding History

Tibra Equities Europe’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-76,000
Closed -$314K – 190
2021
Q2 		$314K Buy
+76,000
New +$344K 0.1% 161
2019
Q3 		– Sell
-10,900
Closed -$297K – 343
2019
Q2 		$297K Buy
+10,900
New +$249K 0.02% 211

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tibra Equities Europe's VYGR Position: Q3 2021 in Review

Tibra Equities Europe sold out of Voyager Therapeutics (VYGR) in Q3 2021, closing a stake of 76,000 shares — an estimated $314K sold.

Tibra Equities Europe first reported a position in VYGR in Q2 2019 and held it in 2 quarters. The position peaked at $314K in Q2 2021. 69 funds tracked by Wall St. Rank hold VYGR as of Q3 2021.

  • Tibra Equities Europe reported no remaining Voyager Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Tibra Equities Europe sold 76,000 Voyager Therapeutics shares in Q3 2021, an estimated $314K.
  • Tibra Equities Europe first reported a position in Voyager Therapeutics in Q2 2019 and held it in 2 quarters.
  • Tibra Equities Europe's Voyager Therapeutics position peaked at $314K in Q2 2021.
  • 69 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2021.

Based on Tibra Equities Europe's 13F filing for Q3 2021, filed 15 Nov 2021.